Trials / Completed
CompletedNCT00881309
To Compare the Efficacy and Safety of Tripterygium (TW) Versus AZA in the Maintenance Therapy for Lupus Nephritis
To Compare the Efficacy and Safety of Tripterygium (TW) vs Aza in the Maintenance Therapy for Lupus Nephritis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 94 (actual)
- Sponsor
- Nanjing University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to: * To access the efficacy of TW compared to Aza in the maintenance therapy for lupus nephritis * To investigate the safety and tolerability of TW versus Aza in the maintenance therapy for lupus nephritis
Detailed description
Tripterygium (TW) is a Chinese traditional patent drugs in treating chronic glomerulonephritis. It has been used to treat lupus nephritis for many years with less side effects. We compare the efficacy and safety of TW vs Aza in the maintenance therapy of lupus nephritis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tripterygium | TW 90mg/d |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2011-04-01
- Completion
- 2011-05-01
- First posted
- 2009-04-15
- Last updated
- 2011-05-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT00881309. Inclusion in this directory is not an endorsement.